Found 57 matching trials
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
PHASE2This phase II clinical trial studies how well craniospinal irradiation (CSI...
Location
University of California San Francisco
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
PHASE1This phase I/II trial tests the safety, side effects best dose and effect o...
Location
Mayo Clinic in Rochester
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
PHASE2This phase II trial studies how well de-escalating the drugs dabrafenib and...
Location
University of Alabama at Birmingham
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
PHASE1Background:
GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Location
National Institutes of Health Clinical Center
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD
PHASE4This phase 4 study will explore, in the context of the present French clini...
Location
Coordinating center (HΓ΄pital de La Timone) and 18 associated centers in France
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
PHASE1This phase Ib/II trial tests the safety, side effects, best dose and how we...
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
PHASE2This phase II/III trial tests whether it is possible to decrease the chance...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis
N/AThe investigators will be evaluating bone marrow composition via magnetic r...
Location
Boston Children's Hospital
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
PHASE2This phase II/III trial tests adding glofitamab to standard of care chemoim...
Location
Multiple Locations
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
PHASE2This phase II trial tests the safety and effectiveness of giving chemothera...
Location
Multiple Locations